Pfizer UK appeals generic Lyrica ruling as patent trial nears
This article was originally published in Scrip
Executive Summary
The launch by Actavis of a generic version of Pfizer's Lyrica (pregabalin) in the UK would not infringe a patent held by Warner-Lambert (part of the Pfizer group) on one of the three uses for which Lyrica is approved, a judge at the High Court has ruled.